# Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

> **NCT00837434** · PHASE4 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 63 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT00837434
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2013-11
- **Final completion:** 2014-01
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2021-09-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837434, "Anti-TNF Agents for the Treatment of Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00837434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*